Cytoplasmic HuR Status Predicts Disease-free Survival in Resected Pancreatic Cancer: A Post-hoc Analysis From the International Phase III ESPAC-3 Clinical Trial

OBJECTIVES: We tested cytoplasmic HuR (cHuR) as a predictive marker for response to chemotherapy by examining tumor samples from the international European Study Group of Pancreatic Cancer-3 trial, in which patients with resected pancreatic ductal adenocarcinoma (PDA) received either gemcitabine (GE...

全面介紹

Na minha lista:
書目詳細資料
發表在:Ann Surg
Main Authors: Tatarian, Talar, Jiang, Wei, Leiby, Benjamin E., Grigoli, Amanda, Jimbo, Masaya, Dabbish, Nooreen, Neoptolemos, John P., Greenhalf, William, Costello, Eithne, Ghaneh, Paula, Halloran, Christopher, Palmer, Daniel, Buchler, Markus, Yeo, Charles J., Winter, Jordan M., Brody, Jonathan R.
格式: Artigo
語言:Inglês
出版: 2018
主題:
Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC6815674/
https://ncbi.nlm.nih.gov/pubmed/27893535
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/SLA.0000000000002088
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍